IL17A and psoriasis: The enrichment results primarily involved pathways such as lipid and atherosclerosis, AGE-RAGE signaling pathway, IL-17 signaling pathway, Th17 cell differentiation, etc., with pathways synergistically contributing to the treatment of psoriasis.